Iowa State University scientists have made a significant breakthrough in scientists' ability to identify specific proteins ...

NULISA employs a sequential immunocomplex capture and release technique to improve the sensitivity of traditional proximity ...

The USA's proteomics market grows steadily, driven by NIH funding in personalized medicine, while Canada is expected to grow ...

Illumina (ILMN) announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, Standard ...

Quantum-Si's NGPS technology disrupts protein analysis market, but recent equity raise and execution risks lead to Sell ...

UK Biobank has today announced the launch of the world's most comprehensive study of the proteins circulating in our bodies, which will transform the study of diseases and their treatments.

Illumina, Inc., a leader in DNA sequencing and array technologies, has launched a pilot proteomics program analyzing 50,000 ...

Platinum Pro is Quantum-Si’s newest Next-Generation Protein Sequencer™ built from the foundation of innovation established by ...

A consortium of 14 pharmaceutical companies will now use those samples and start the largest proteomics study to date.

Genomics provides an overview of the complete set of genetic instructions provided by the DNA, while proteomics studies dynamic protein products and their interactions. Genetics and genomics both play ...

Sapient will be an Alamar certified service provider for Alamar's NULISAseq Inflammation panel and its NULISAseq CNS Disease panel.